US 12053534
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
granted A61KA61K2121/00A61K51/0474
Quick answer
US patent 12053534 (Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2121/00, A61K51/0474, A61K51/1045, A61K51/1093